BiVACOR's Total Artificial Heart Achieves Milestone First Human Implantation

The groundbreaking device, utilizing magnetic levitation technology, kept a patient alive for eight days until a transplant.

BiVACOR's TAH is a rotary pump with an impeller-based design, minimizing blood damage.
The device was part of an FDA Early Feasibility Study at the Texas Heart Institute.
Traditional artificial hearts last 12 to 18 months, but the TAH design aims for indefinite operation.
Heart failure affects 26 million globally, with limited donor hearts available each year.
The successful implantation marks a significant advancement in artificial heart technology.